跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SUNOSI - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SUNOSI
Authorized
STANDARD
SUNOSI
Axsome Malta Ltd.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e6b44a76e4a20785
Company
Axsome Malta Ltd.
Type
Standard
Approval Details
Approval Id
e6b44a76e4a20785
Drug Approval Canada Name
SUNOSI
Product Name
SUNOSI
Status
Marketed
Status Date
2022-11-17
Original Market Date
2021-08-03
Din
02515814
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:20.80
Atc Original
N06BA14 SOLRIAMFETOL
Atc Name
n 06 ba 14
Aig Number
0162888001
Company Name
Axsome Malta Ltd.
Company Address
Pinto Business Centre, Level 4, Office 4, Mill Street, Qormi, --, Malta, QRM3104
Company Detail Path
/organization/axsome-malta-ltd
Company Information
Pharmaceutical Company Name
Axsome Malta Ltd.
Country Name
Malta
Active Ingredients
SOLRIAMFETOL (SOLRIAMFETOL HYDROCHLORIDE)
75 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e6b44a76e4a20785
Type
Standard
Back to Health Canada Approvals